ストックスクリーナーアプリを入手
30.93
1.06%
-0.33
プレマーケット:
30.43
-0.50
-1.62%
Atricure Inc (ATRC) 最新ニュース
Oversold Conditions For AtriCure (ATRC) - Nasdaq
AtriCure to Participate in the Citizens Life Sciences Conference - Business Wire
Aug Opening: Is XWELL Inc exposed to currency risksSell Signal & Daily Profit Focused Stock Screening - baoquankhu1.vn
Price-Driven Insight from (ATRC) for Rule-Based Strategy - Stock Traders Daily
Nasdaq Moves: Is QDEL likely to announce a buybackInflation Watch & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Will AtriCure Inc. stock go up in YEARJuly 2025 Spike Watch & Safe Capital Preservation Plans - mfd.ru
Hood River Capital Management LLC's Strategic Acquisition of Atr - GuruFocus
AtriCure (NASDAQ:ATRC) Cut to Hold at Zacks Research - MarketBeat
Is AtriCure (NASDAQ:ATRC) Facing New Pressure In The Nasdaq Index? - Kalkine Media
Decoding AtriCure Inc (ATRC): A Strategic SWOT Insight - GuruFocus
AtriCure, Inc. SEC 10-K Report - TradingView
COR's MWI Animal Health to Merge With Covetrus in $3.5 Billion Deal - Finviz
Atricure (ATRC) Receives a Buy from Needham - The Globe and Mail
AtriCure Earnings Call Highlights Growth Amid Headwinds - TipRanks
Demystifying AtriCure: Insights From 6 Analyst Reviews - Benzinga
ATRC: Canaccord Genuity Lowers Price Target, Maintains Buy Ratin - GuruFocus
Needham reiterates Buy on AtriCure stock, keeps $45 target - Investing.com UK
Needham reiterates Buy on AtriCure stock, keeps $45 target By Investing.com - Investing.com Nigeria
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026? - Finviz
UBS Adjusts AtriCure Price Target to $55 From $60, Maintains Buy Rating - marketscreener.com
UBS Maintains 'Buy' Rating on AtriCure (ATRC), Lowers Price Targ - GuruFocus
Citizens Jmp Cuts AtriCure (NASDAQ:ATRC) Price Target to $52.00 - MarketBeat
AtriCure (ATRC) Analyst Maintains Rating, Lowers Price Target to $52 | ATRC Stock News - GuruFocus
AtriCure Delivers 15% Revenue Growth In FY25, Projects 12-14% Growth In FY26 - Nasdaq
This Masimo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
AtriCure, Inc. (NASDAQ:ATRC) Q4 2025 Earnings Call Transcript - Insider Monkey
AtriCure, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Why AtriCure (ATRC) Is Down 12.9% After Issuing 2026 Profitability Guidance And Revenue Outlook - simplywall.st
BTIG Research Reaffirms "Buy" Rating for AtriCure (NASDAQ:ATRC) - MarketBeat
Oppenheimer downgrades AtriCure stock rating on competitive concerns - Investing.com UK
Oppenheimer downgrades AtriCure stock rating on competitive concerns By Investing.com - Investing.com India
Canaccord Genuity lowers AtriCure stock price target on valuation - Investing.com UK
Canaccord Genuity lowers AtriCure stock price target on valuation By Investing.com - Investing.com India
AtriCure Q4 2025 revenue up 13.1% to USD 140.5M - Medical Buyer
ATRC Downgraded by Oppenheimer to 'Perform' | ATRC Stock News - GuruFocus
Citizens lowers AtriCure stock price target on valuation adjustment By Investing.com - Investing.com Australia
AtriCure (ATRC): BTIG Reiterates Buy Rating and $54 PT | ATRC St - GuruFocus
AtriCure posts Q4 beats on 13% growth, analysts label it 'undervalued' despite rising competition - MassDevice
Citizens lowers AtriCure stock price target on valuation adjustment - Investing.com UK
AtriCure Inc (ATRC) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
AtriCure reports surprise Q4 profit on strong worldwide revenue growth - AlphaStreet News
Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings - sharewise.com
AtriCure Q4 Earnings Call Highlights - MarketBeat
AtriCure (ATRC) Q4 2025 Earnings Call Transcript - The Globe and Mail
AtriCure Inc (NASDAQ:ATRC) Stock Surges on Q4 2025 Earnings Beat and Profitability Milestone - ChartMill
ATRC Projects FY26 Revenue Between $600M and $610M - GuruFocus
AtriCure (ATRC) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance
1.62%
0.30%
大文字化:
|
ボリューム (24 時間):